# Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

> **NCT05629494** · PHASE4 · RECRUITING · sponsor: **Albany Medical College** · enrollment: 198 (estimated)

## Conditions studied

- Prostate Cancer
- Prostate Inflammation
- PSA

## Interventions

- **DRUG:** Ibuprofen 400 mg, TID
- **DIAGNOSTIC_TEST:** PSA test

## Key facts

- **NCT ID:** NCT05629494
- **Lead sponsor:** Albany Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-27
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 198 (ESTIMATED)
- **Last updated:** 2024-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05629494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05629494, "Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05629494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*